Finance

Lists
Why is EII up 8,35%?
Dive Deeper
EII:FRA
Eisai Co Ltd
29,33 €
+8,35%
(+2,26) 1D
9-ноя., 22:00:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EII...
Open
28,19 €
High
29,33 €
Low
28,19 €
Mkt. cap
1,47 трлн
Avg. vol.
227,00
Volume
225,00
52-wk high
31,02 €
52-wk low
19,70 €
No. of employees
11 миң
Open
28,19 €
High
29,33 €
Low
28,19 €
Mkt. cap
1,47 трлн
Avg. vol.
227,00
Volume
225,00
52-wk high
31,02 €
52-wk low
19,70 €
No. of employees
11 миң
News stories
From web sources and news partners
WGN Radio 720
WGN Radio 720
·
28 мүнөт мурун
Terry Savage: Good news regarding the Dow
Quantisnow
Quantisnow
·
18 мүнөт мурун
Autoliv Declares Increased Quarterly Dividend
RealMoney Pro
RealMoney Pro
·
55 мүнөт мурун
A Look at Monday’s Charts
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
About Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Employees10,5 миң
Founded1941-ж., 6-дек.
HeadquartersBunkyo City, Tokyo, Япония
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
197,36 млд
219,94 млд
205,43 млд
234,33 млд
Cost of goods sold
45,52 млд
51,08 млд
52,02 млд
51,09 млд
Cost of revenue
45,52 млд
51,08 млд
52,02 млд
51,09 млд
Research and development expenses
36,74 млд
39,20 млд
43,94 млд
43,71 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,06 млд
111,72 млд
108,23 млд
114,83 млд
Operating expense
138,36 млд
148,82 млд
163,92 млд
158,51 млд
Total operating expenses
183,88 млд
199,90 млд
215,94 млд
209,60 млд
Operating income
13,48 млд
20,03 млд
-10,51 млд
24,73 млд
Other non operating income
1,00 млн
-1,00 млн
-66,00 млн
-2,00 млн
EBT including unusual items
14,53 млд
22,00 млд
-7,94 млд
25,28 млд
EBT excluding unusual items
14,34 млд
22,00 млд
-10,55 млд
25,28 млд
Income tax expense
4,00 млд
4,16 млд
-4,75 млд
6,13 млд
Effective tax rate
27,51%
18,90%
59,77%
24,25%
Other operating expenses
-2,44 млд
-2,10 млд
250,00 млн
-28,00 млн
Net income
10,16 млд
17,18 млд
-3,25 млд
18,24 млд
Net profit margin
5,15%
7,81%
-1,58%
7,78%
Earnings per share
-
-
-
-
Interest and investment income
2,30 млд
3,40 млд
462,00 млн
2,51 млд
Interest expense
-1,44 млд
-1,43 млд
-439,00 млн
-1,96 млд
Net interest expenses
856,00 млн
1,97 млд
23,00 млн
556,00 млн
Depreciation and amortization charges
-
-
11,51 млд
-
EBITDA
23,29 млд
30,10 млд
-530,00 млн
34,15 млд
Gain or loss from assets sale
1,31 млд
-
1,40 млд
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору